Crane Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Hold
9,346
0.34% 17
2026
Q1
$2.19M Hold
9,346
0.33% 16
2025
Q4
$1.96M Sell
9,346
-648
-6% -$128K 0.3% 17
2025
Q3
$1.91M Hold
9,994
0.3% 19
2025
Q2
$1.57M Hold
9,994
0.26% 20
2025
Q1
$1.52M Buy
9,994
+169
+2% +$26.4K 0.27% 17
2024
Q4
$1.42M Sell
9,825
-882
-8% -$137K 0.25% 17
2024
Q3
$1.71M Hold
10,707
0.31% 16
2024
Q2
$1.57M Hold
10,707
0.3% 17
2024
Q1
$1.63M Buy
10,707
+2,951
+38% +$470K 0.33% 15
2023
Q4
$1.25M Buy
+7,756
New +$1.19M 0.28% 15
2023
Q1
Sell
-8,358
Closed -$1.48M 27
2022
Q4
$1.48M Hold
8,358
0.6% 12
2022
Q3
$1.36M Buy
+8,358
New +$1.41M 0.7% 12

Other funds holding JNJ

Crane Advisory's JNJ Position: Q2 2026 in Review

Crane Advisory held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 9,346 shares worth $2.34M. The position accounts for 0.34% of the portfolio, ranked #17.

Crane Advisory first reported a position in JNJ in Q3 2022 and has held it in 13 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Crane Advisory held 9,346 shares of Johnson & Johnson worth $2.34M as of Q2 2026.
  • Crane Advisory left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.34% of Crane Advisory's portfolio in Q2 2026, its #17 holding.
  • Crane Advisory first reported a position in Johnson & Johnson in Q3 2022 and has held it in 13 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Crane Advisory's 13F filing for Q2 2026, filed 20 Jul 2026.